Shanghai Pioneer Holding Ltd

1345.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1345.HK stands at 2.7B. In comparison, 0241.HK has a market cap of 75.1B. Regarding current trading prices, 1345.HK is priced at HK$2.30, while 0241.HK trades at HK$4.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1345.HK currently has a P/E ratio of 23.00, whereas 0241.HK's P/E ratio is 33.29. In terms of profitability, 1345.HK's ROE is +0.10%, compared to 0241.HK's ROE of +0.14%. Regarding short-term risk, 1345.HK is more volatile compared to 0241.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1345.HK.Check 0241.HK's competition here

1345.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1345.HK stands at 2.7B. In comparison, 3613.HK has a market cap of 6.5B. Regarding current trading prices, 1345.HK is priced at HK$2.30, while 3613.HK trades at HK$7.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1345.HK currently has a P/E ratio of 23.00, whereas 3613.HK's P/E ratio is 16.51. In terms of profitability, 1345.HK's ROE is +0.10%, compared to 3613.HK's ROE of +0.13%. Regarding short-term risk, 1345.HK is more volatile compared to 3613.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1345.HK.Check 3613.HK's competition here

1345.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1345.HK stands at 2.7B. In comparison, 1110.HK has a market cap of 294.8M. Regarding current trading prices, 1345.HK is priced at HK$2.30, while 1110.HK trades at HK$0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1345.HK currently has a P/E ratio of 23.00, whereas 1110.HK's P/E ratio is 50.00. In terms of profitability, 1345.HK's ROE is +0.10%, compared to 1110.HK's ROE of +0.01%. Regarding short-term risk, 1345.HK is less volatile compared to 1110.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1345.HK.Check 1110.HK's competition here

1345.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1345.HK stands at 2.7B. In comparison, 3390.HK has a market cap of 245.9M. Regarding current trading prices, 1345.HK is priced at HK$2.30, while 3390.HK trades at HK$0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1345.HK currently has a P/E ratio of 23.00, whereas 3390.HK's P/E ratio is -6.87. In terms of profitability, 1345.HK's ROE is +0.10%, compared to 3390.HK's ROE of -0.05%. Regarding short-term risk, 1345.HK is less volatile compared to 3390.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1345.HK.Check 3390.HK's competition here

1345.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1345.HK stands at 2.7B. In comparison, 0348.HK has a market cap of 70.9M. Regarding current trading prices, 1345.HK is priced at HK$2.30, while 0348.HK trades at HK$0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1345.HK currently has a P/E ratio of 23.00, whereas 0348.HK's P/E ratio is -9.20. In terms of profitability, 1345.HK's ROE is +0.10%, compared to 0348.HK's ROE of +0.25%. Regarding short-term risk, 1345.HK is less volatile compared to 0348.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1345.HK.Check 0348.HK's competition here

1345.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1345.HK stands at 2.7B. In comparison, 0574.HK has a market cap of 59M. Regarding current trading prices, 1345.HK is priced at HK$2.30, while 0574.HK trades at HK$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1345.HK currently has a P/E ratio of 23.00, whereas 0574.HK's P/E ratio is -0.80. In terms of profitability, 1345.HK's ROE is +0.10%, compared to 0574.HK's ROE of +0.42%. Regarding short-term risk, 1345.HK is more volatile compared to 0574.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1345.HK.Check 0574.HK's competition here

1345.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1345.HK stands at 2.7B. In comparison, 2211.HK has a market cap of 45.3M. Regarding current trading prices, 1345.HK is priced at HK$2.30, while 2211.HK trades at HK$0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1345.HK currently has a P/E ratio of 23.00, whereas 2211.HK's P/E ratio is -1.59. In terms of profitability, 1345.HK's ROE is +0.10%, compared to 2211.HK's ROE of -0.07%. Regarding short-term risk, 1345.HK is more volatile compared to 2211.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1345.HK.Check 2211.HK's competition here